Nanox shared new clinical findings about its AI tool for spotting aortic valve calcification at the TCT Conference.

Nov 3, 2026, 2:17 AM ETTrialRead the original at globenewswire.com

Good for NNOX

Nanox's investigational software detected 98.3% of cases and correctly ruled out 96.6% of non-cases, alongside an 84% reporting gap. This supports its scan software, but the source reports no approval or sales.

NNOX · Nanox Imaging Ltd.

AI read · Good for NNOX

The AI's read

These results give Nanox evidence that its software can find calcification missed in routine CT reports. Its post-scan tool could help care teams spot cases using scans they already take. But the solution is still being tested, and the story reports no approval or sales.

Get alerts for NNOX

Follow Nanox Imaging Ltd. (NNOX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NNOX

Free on the App Store and Google Play, or on the web.